Clinical Operational Research Unit, Department of Mathematics, University College London, London, UK.
Department of Management Science, University of Strathclyde, Glasgow, UK.
Expert Rev Pharmacoecon Outcomes Res. 2021 Oct;21(5):985-994. doi: 10.1080/14737167.2021.1894931. Epub 2021 Mar 18.
The economic evaluation of vaccines has attracted a great deal of controversy. In the academic literature, several vaccination advocates argue that the evaluation frame for vaccines should be expanded to give a more complete picture of their benefits. We seek to contribute to the debate and facilitate informed dialogue about vaccine assessment using visualization, as able to support both deliberation by technical committees about the substance of evaluation and communication of the underlying rationale to non-experts.
We present two visualizations, an Individual Risk Plot (IRP), and a Population Impact Plot (PIP), both showing the beneficiary population on one axis and the degree of individual benefit and cost of an individual dose on the second axis. We sketch out such graphs for 10 vaccines belonging to the UK routine childhood immunization schedule and present our own analysis for the rotavirus and meningitis B vaccines.
While the IRPs help classify diseases by morbidity and mortality, the PIPs display the health and economic loss averted after introducing a vaccine, allowing further comparisons.
The visualizations presented, albeit open to provide an increasingly complete accounting of the value of vaccination, ensure consistency of approach where comparative judgments are most needed.
疫苗的经济学评价引起了广泛争议。在学术文献中,一些疫苗支持者认为,应该扩大疫苗的评估框架,以更全面地了解其效益。我们希望通过可视化来为辩论做出贡献,并促进关于疫苗评估的知情对话,因为它既能支持技术委员会就评估的实质内容进行审议,也能向非专家传达基本原理。
我们展示了两种可视化图表,即个体风险图(IRP)和人群影响图(PIP),两者都在一个轴上显示受益人群,在另一个轴上显示个体剂量的个体获益和成本程度。我们为英国常规儿童免疫计划中的 10 种疫苗绘制了这样的图表,并对轮状病毒疫苗和脑膜炎 B 疫苗进行了我们自己的分析。
IRP 有助于根据发病率和死亡率对疾病进行分类,而 PIP 则显示了引入疫苗后所避免的健康和经济损失,从而可以进行进一步比较。
虽然所呈现的可视化图(尽管可以提供越来越完整的疫苗价值核算),但在最需要进行比较判断的地方,确保了方法的一致性。